MRK-623

CAS No. 461449-78-5

MRK-623( MRK623 )

Catalog No. M14556 CAS No. 461449-78-5

MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MRK-623
  • Note
    Research use only, not for human use.
  • Brief Description
    MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist.
  • Description
    MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist.
  • In Vitro
    MRK-623 shows efficacy at human GABAA receptor subtypes expressed in L(tk-) cells measured by whole cell patch-clamp electrophysiology.
  • In Vivo
    MRK-623 (oral gavage; 0.3, 1, and 3 mg/kg; once) shows anxiolytic effects in the rat elevated plus maze assay. Animal Model:RatDosage:0.3, 1, and 3 mg/kg Administration:Oral gavage; 0.3, 1, and 3 mg/kg; once Result:Showed 78% BZ site occupancy at 3 mg/kg, with an ID50 of 0.8 mg/kg.
  • Synonyms
    MRK623
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    GAT
  • Recptor
    GAT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    461449-78-5
  • Formula Weight
    348.381
  • Molecular Formula
    C20H17FN4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    2-(3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo(1,2-a)pyrimidin-7-yl)-propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shinday NM, et al. Neuropsychopharmacology. 2013 May;38(6):1006-14.
molnova catalog
related products
  • Alprazolam

    Alprazolam (D-65MT;U 31889) is a triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities.

  • (R)-Baclofen

    A derivative of the neurotransmitter GABA that acts as a GABAB receptor agonist; also blocks α2δ subunit-containing voltage-dependent calcium channel (VDCC) with Ki of 156 uM.

  • Pagoclone

    A potent, orally active GABAA receptor agonist with high affinity (0.7-9.1nM) to the benzodiazepine binding site of GABAA receptors containing either an α1, α2, α3 or α5 subunit.